Interest Group on Biomarkers in Pediatric Therapeutics Forms
A new biomarkers special interest group in pediatric therapeutics has been established with the primary goal of promoting information exchange and interactions in the application of biomarkers for diagnosis, prognostication, evaluation of disease progression, response to therapy and toxicity in the different pediatric subpopulations. Other goals are to promote initiatives that address knowledge gaps and address issues preventing the implementation of research in this area and to collect and disseminate information related to pediatric biomarkers. In addition, the group will also address pre-clinical biomarkers related to the development of new molecular entities or toxicity evaluation of new drugs tested or developed at NIH.
The first in a series of monthly presentations is scheduled for Tuesday, Jan. 12 at noon in Rockledge II, Rms. 9100/9104. The lecture is titled “Application of Metabolomics To Provide Pediatric Biomarkers,” given by Dr. Susan Sumner, director, NIH Eastern Regional Comprehensive Metabolomics Resource Core, RTI International.
For registration, contact George Giacoia at firstname.lastname@example.org.